410 related articles for article (PubMed ID: 34069635)
41. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
Takahara I; Akazawa Y; Tabuchi M; Matsuda K; Miyaaki H; Kido Y; Kanda Y; Taura N; Ohnita K; Takeshima F; Sakai Y; Eguchi S; Nakashima M; Nakao K
PLoS One; 2017; 12(3):e0170591. PubMed ID: 28278289
[TBL] [Abstract][Full Text] [Related]
42. Ablation of catalase promotes non-alcoholic fatty liver via oxidative stress and mitochondrial dysfunction in diet-induced obese mice.
Shin SK; Cho HW; Song SE; Bae JH; Im SS; Hwang I; Ha H; Song DK
Pflugers Arch; 2019 Jun; 471(6):829-843. PubMed ID: 30617744
[TBL] [Abstract][Full Text] [Related]
43. Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity.
Win S; Than TA; Le BH; García-Ruiz C; Fernandez-Checa JC; Kaplowitz N
J Hepatol; 2015 Jun; 62(6):1367-74. PubMed ID: 25666017
[TBL] [Abstract][Full Text] [Related]
44. Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E).
Bartolini D; Torquato P; Barola C; Russo A; Rychlicki C; Giusepponi D; Bellezza G; Sidoni A; Galarini R; Svegliati-Baroni G; Galli F
J Nutr Biochem; 2017 Sep; 47():120-131. PubMed ID: 28628909
[TBL] [Abstract][Full Text] [Related]
45. Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice.
Jeong HS; Kim KH; Lee IS; Park JY; Kim Y; Kim KS; Jang HJ
Biomed Pharmacother; 2017 Apr; 88():625-634. PubMed ID: 28142119
[TBL] [Abstract][Full Text] [Related]
46. Excess fructose and fatty acids trigger a model of non‑alcoholic fatty liver disease progression in vitro: Protective effect of the flavonoid silybin.
Grasselli E; Baldini F; Vecchione G; Oliveira PJ; Sardão VA; Voci A; Portincasa P; Vergani L
Int J Mol Med; 2019 Aug; 44(2):705-712. PubMed ID: 31173180
[TBL] [Abstract][Full Text] [Related]
47. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
[TBL] [Abstract][Full Text] [Related]
48. Effects of
Mun J; Park J; Yoon HG; You Y; Choi KC; Lee YH; Kim K; Lee J; Kim OK; Jun W
J Med Food; 2019 Dec; 22(12):1262-1270. PubMed ID: 31834842
[TBL] [Abstract][Full Text] [Related]
49. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation.
Barbier-Torres L; Fortner KA; Iruzubieta P; Delgado TC; Giddings E; Chen Y; Champagne D; Fernández-Ramos D; Mestre D; Gomez-Santos B; Varela-Rey M; de Juan VG; Fernández-Tussy P; Zubiete-Franco I; García-Monzón C; González-Rodríguez Á; Oza D; Valença-Pereira F; Fang Q; Crespo J; Aspichueta P; Tremblay F; Christensen BC; Anguita J; Martínez-Chantar ML; Rincón M
Nat Commun; 2020 Jul; 11(1):3360. PubMed ID: 32620763
[TBL] [Abstract][Full Text] [Related]
50. Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells.
Liu H; Yan J; Guan F; Jin Z; Xie J; Wang C; Liu M; Liu J
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Apr; 1868(4):159287. PubMed ID: 36690321
[TBL] [Abstract][Full Text] [Related]
51. Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device.
Gori M; Simonelli MC; Giannitelli SM; Businaro L; Trombetta M; Rainer A
PLoS One; 2016; 11(7):e0159729. PubMed ID: 27438262
[TBL] [Abstract][Full Text] [Related]
52. Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.
Fontes A; Alemany-Pagès M; Oliveira PJ; Ramalho-Santos J; Zischka H; Azul AM
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426291
[TBL] [Abstract][Full Text] [Related]
53. Effect of triggering receptor expressed on myeloid cells 2-associated alterations on lipid metabolism in macrophages in the development of non-alcoholic fatty liver disease.
Ji PX; Chen YX; Ni XX; Miao Q; Hua J
J Gastroenterol Hepatol; 2024 Feb; 39(2):369-380. PubMed ID: 38012119
[TBL] [Abstract][Full Text] [Related]
54. GBA3 promotes fatty acid oxidation and alleviates non-alcoholic fatty liver by increasing CPT2 transcription.
Li J; Ni Y; Zhang Y; Liu H
Aging (Albany NY); 2024 Feb; 16(5):4591-4608. PubMed ID: 38428407
[TBL] [Abstract][Full Text] [Related]
55. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
[TBL] [Abstract][Full Text] [Related]
56. The novel resveratrol derivative 3,5-diethoxy-3',4'-dihydroxy-trans-stilbene induces mitochondrial ROS-mediated ER stress and cell death in human hepatoma cells in vitro.
Park JW; Choi WG; Lee PJ; Chung SW; Kim BS; Chung HT; Cho S; Kim JH; Kang BH; Kim H; Kim HP; Back SH
Acta Pharmacol Sin; 2017 Nov; 38(11):1486-1500. PubMed ID: 28795692
[TBL] [Abstract][Full Text] [Related]
57. Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling.
Kim MH; Seong JB; Huh JW; Bae YC; Lee HS; Lee DS
Redox Biol; 2020 Jan; 28():101315. PubMed ID: 31505325
[TBL] [Abstract][Full Text] [Related]
58. Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.
Zeng X; Yang J; Hu O; Huang J; Ran L; Chen M; Zhang Y; Zhou X; Zhu J; Zhang Q; Yi L; Mi M
Antioxid Redox Signal; 2019 Jan; 30(2):163-183. PubMed ID: 29310441
[No Abstract] [Full Text] [Related]
59. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice.
Hong SA; Jung IR; Choi SE; Hwang Y; Lee SJ; Son Y; Heo YJ; Cui R; Han SJ; Kim HJ; Lee KW; Kang Y
Sci Rep; 2019 Nov; 9(1):17839. PubMed ID: 31780766
[TBL] [Abstract][Full Text] [Related]
60. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
